FDA Issues Final Guidance on Drug Manufacturing Processes
By Staff Reports
Tuesday, November 20, 2012
The FDA's Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research adopted final guidance on the harmonization of manufacturing processes for new drug substances and products, including steps designed to reduce impurities.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.